to see how eladi kashay works in complaints of urinary system caused because of vatshtheela

A Randomized Open Controlled Clinical Study To Evaluate The Efficacy Of Eladi Kashay In Vatashtheela With Special Reference To Benign Prostatic Hyperplasia

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/06/043124

Enrollment

Registered

2022-06-09

Start date

Unknown

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

Intervention1: Eladi Kashay: Eladi Kashay 40ml OD Duration: 28 days Control Intervention1: Tamsulosin: Tab.Tamsulosin 0.4mg HS Duration: 28 days

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients with AUA symptom score greater than 8 and less than 19 2) Rectal Examination consistent with BPH. 3) Prostate volume greater than 26cc.

Exclusion criteria

Exclusion criteria: 1) Patients with severe BPH (AUA score greater than 26) 2) Patients with Malignancy, HIV, HBsAg, VDRL positive. 3) Patients suffering from systematic diseases like DM, HTN. 4) Patients with acute urinary retention. 5) Obstructive urinary calculi, bladder neck stenosis, cystic calculi. 6) Patients with pyonephrosis 7) Patients with acute and chronic renal failure.

Design outcomes

Primary

Measure	Time frame
Scale of following symptoms 1) Incomplete emptying of bladder 2) frequency 3) Intermittency 4) urgency 5) weak stream 6) straining 7) nocturiaTimepoint: At 1 week interval	—

Secondary

Measure	Time frame
Decrease in Prostate Size and post voidal urine volumeTimepoint: 28 days	—

Countries

India

Contacts

Public ContactDr Rutuja Ramesh Gore

Yashwant Ayurvedic Medical College, Post Graduate Training And Research Center, Kodoli

drardrathorat@gmail.com9168223088

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026